MACROD2 knockdown sensitizes tamoxifen resistant cells to tamoxifen treatment and reduces tumor formation of tamoxifen resistant cells in a xenograft model, suggesting that MACROD2 could become an important molecular target in the treatment of tamoxifen resistant breast cancer. Here, MACROD2 is linked to breast carcinoma.